https://orcid.org/0000-0001-8032-7959
Citations (17)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Minli Qiu, Liudan Tu, Minjing Zhao, Mingcan Yang, Jun Qi, Ya Xie & Jieruo Gu. (2022) Ataxia-televangelist mutated (ATM)/ ATR serine/threonine kinase (ATR)-mediated RAD51 recombinase (RAD51) promotes osteogenic differentiation and inhibits osteoclastogenesis in osteoporosis. Bioengineered 13:2, pages 4201-4211.
Read now
Read now
Chaoqun Huang, Jiuyang Liu, Liang He, Fubing Wang, Bin Xiong, Yan Li & Xiaojun Yang. (2021) The long noncoding RNA noncoding RNA activated by DNA damage (NORAD)-microRNA-496-Interleukin-33 axis affects carcinoma-associated fibroblasts-mediated gastric cancer development. Bioengineered 12:2, pages 11738-11755.
Read now
Read now
Qian Zhang, Yunen Liu, Peng Chen, Xiuyun Shi, Ying Liu, Lin Shi, Peifang Cong, Shun Mao, Cangci Tong, Cheng Du & Mingxiao Hou. (2021) Solute carrier family 12 member 8 (SLC12A8) is a potential biomarker and related to tumor immune cell infiltration in bladder cancer. Bioengineered 12:1, pages 4946-4961.
Read now
Read now
Tao Meng, Zhong Tong, Ming-Ya Yang, Yan Zhang, Yu Liu, Zhen-Zhen Wang, Li-Xin Zhu & Jin Wu. (2021) Immune implication of FAM83D gene in hepatocellular carcinoma. Bioengineered 12:1, pages 3578-3592.
Read now
Read now
Articles from other publishers (13)
Vanessa Klapp, Beatriz Álvarez-Abril, Giuseppe Leuzzi, Guido Kroemer, Alberto Ciccia & Lorenzo Galluzzi. (2023) The DNA Damage Response and Inflammation in Cancer. Cancer Discovery 13:7, pages 1521-1545.
Crossref
Crossref
Hongda Li, Haiwen Zhuang, Tengfei Gu, Guangyu Li, Yuhang Jiang, Sanrong Xu & Qing Zhou. (2023) RAD54L promotes progression of hepatocellular carcinoma via the homologous recombination repair pathway. Functional & Integrative Genomics 23:2.
Crossref
Crossref
Mingang Pan, Yu Sha, Jianguo Qiu, Yunmeng Chen, Lele Liu, Muyu Luo, Ailong Huang & Jie Xia. (2023) RAD51 Inhibition Shows Antitumor Activity in Hepatocellular Carcinoma. International Journal of Molecular Sciences 24:9, pages 7905.
Crossref
Crossref
Paula Fernández-Palanca, Tania Payo-Serafín, Carolina Méndez-Blanco, Beatriz San-Miguel, María J. Tuñón, Javier González-Gallego & José L. Mauriz. (2023) Neuropilins as potential biomarkers in hepatocellular carcinoma: a systematic review of basic and clinical implications. Clinical and Molecular Hepatology 29:2, pages 293-319.
Crossref
Crossref
Zhixian Zhou, Huan Yin, Suye Suye, Jiarong He & Chun Fu. (2023) Pan-cancer analysis of the prognostic and immunological role of Fanconi anemia complementation group E. Frontiers in Genetics 13.
Crossref
Crossref
Moqin Qiu, Yingchun Liu, Qiuling Lin, Yanji Jiang, Zihan Zhou, Qiuping Wen, Xiumei Liang, Xianguo Zhou & Hongping Yu. (2023) A functional variant in the RAD51 3′ UTR is associated with survival of hepatocellular carcinoma patients. Gene 851, pages 146964.
Crossref
Crossref
Fei Xu, Wen‐qiang Cui, Cun Liu, Fubin Feng, Ruijuan Liu, Jingtao Zhang & Chang‐gang Sun. (2022) Prognostic biomarkers correlated with immune infiltration in non‐small cell lung cancer. FEBS Open Bio 13:1, pages 72-88.
Crossref
Crossref
Fengyang Jing, Jianyun Zhang, Xinjia Cai, Xuan Zhou, Jiaying Bai, Heyu Zhang & Tiejun Li. (2022) Screening for Biomarkers for Progression from Oral Leukoplakia to Oral Squamous Cell Carcinoma and Evaluation of Diagnostic Efficacy by Multiple Machine Learning Algorithms. Cancers 14:23, pages 5808.
Crossref
Crossref
Mahzeiar Samadaei, Daniel Senfter, Sibylle Madlener, Karolina Uranowska, Christine Hafner, Michael Trauner, Nataliya Rohr‐Udilova & Matthias Pinter. (2022) Targeting DNA repair to enhance the efficacy of sorafenib in hepatocellular carcinoma. Journal of Cellular Biochemistry 123:10, pages 1663-1673.
Crossref
Crossref
Hengrui Liu & Jieling Weng. (2022) A Pan-Cancer Bioinformatic Analysis of RAD51 Regarding the Values for Diagnosis, Prognosis, and Therapeutic Prediction. Frontiers in Oncology 12.
Crossref
Crossref
Menglin He, Cheng Hu, Jian Deng, Hui Ji & Weiqian Tian. (2021) Identification of a novel glycolysis-related signature to predict the prognosis of patients with breast cancer. World Journal of Surgical Oncology 19:1.
Crossref
Crossref
Chin-Chuan Chen, Chi-Yuan Chen, Shu-Fang Cheng, Tzong-Ming Shieh, Yann-Lii Leu, Wen-Yu Chuang, Kuang-Ting Liu, Shir-Hwa Ueng, Yin-Hwa Shih, Li-Fang Chou & Tong-Hong Wang. (2021) Hydroxygenkwanin Increases the Sensitivity of Liver Cancer Cells to Chemotherapy by Inhibiting DNA Damage Response in Mouse Xenograft Models. International Journal of Molecular Sciences 22:18, pages 9766.
Crossref
Crossref
Peng Lin, Rui-zhi Gao, Rong Wen, Yun He & Hong Yang. (2021) DNA Damage Repair Profiles Alteration Characterize a Hepatocellular Carcinoma Subtype With Unique Molecular and Clinicopathologic Features. Frontiers in Immunology 12.
Crossref
Crossref